LianBio Email Format

Biotechnology ResearchShanghai, China11-50 Employees

LianBio is a biotechnology company focused on accelerating the development and broader availability of innovative medicines for patients in China and other major Asian markets. It pursues this goal through partnerships that enable access to cutting-edge therapeutic discoveries. The organization operates at the intersection of research and development, aiming to streamline pathways from discovery to patient access in Asia. Its target market includes patients across China and wider Asian markets, as well as partner organizations seeking to bring new therapies to these regions. 

Based in Shanghai, in the Shanghai region, LianBio is a small to mid-sized biotechnology firm. In early 2024, the company disclosed plans to voluntary delist its American Depositary Shares from Nasdaq and to wind down operations, signaling a strategic shift that includes asset sales.

Get verified LianBio emails free

Company overview Employee directory